Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chondrosarcoma × Heavy Ion Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 6 Prostatic Neoplasms 4 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Radiation Injuries 1 Pancreatic Cancer Non-resectable 1 Ovarian Neoplasms 1 Osteosarcoma 1 Meningioma 1 Melanoma 1 Locally Advanced Pancreatic Cancer 1 Glioma 1 Chondrosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Ifosfamide 4 Gemcitabine 4 Filgrastim 4 Docetaxel 4 Proton Therapy 3 Doxorubicin 3 regorafenib 2 enasidenib 2 belinostat 2 Sunitinib 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 HhAntag691 2 Fluorouracil 2 Etoposide 2 Epirubicin 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Bevacizumab 2 venetoclax 1 toripalimab 1 temsirolimus 1 tanespimycin 1 spartalizumab 1 resiquimod 1 poly ICLC 1 perifosine 1 pegfilgrastim 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01182753 2010-08-17

CSP12C

Heidelberg University

Phase 3 Unknown

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡